{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:30:47Z","timestamp":1762867847592,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.hfc.2019.06.006","type":"journal-article","created":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T16:13:22Z","timestamp":1563639202000},"page":"455-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Heart Failure and Changes in Kidney Function"],"prefix":"10.1016","volume":"15","author":[{"given":"Tamar S.","family":"Polonsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George L.","family":"Bakris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.hfc.2019.06.006_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ejhf.35","article-title":"The kidney in congestive heart failure: 'are natriuresis, sodium, and diuretics really the good, the bad and the ugly?","volume":"16","author":"Verbrugge","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.hfc.2019.06.006_bib2","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrneph.2016.113","article-title":"Heart failure and kidney dysfunction: epidemiology, mechanisms and management","volume":"12","author":"Schefold","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.hfc.2019.06.006_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2005.07.067","article-title":"Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?","volume":"47","author":"Schrier","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.hfc.2019.06.006_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor of outcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hfc.2019.06.006_bib5","doi-asserted-by":"crossref","first-page":"e001174","DOI":"10.1161\/JAHA.114.001174","article-title":"Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure","volume":"3","author":"Ueda","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.hfc.2019.06.006_bib6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.hfc.2019.06.006_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cardfail.2016.07.440","article-title":"Worsening renal function during management for chronic heart failure with reduced ejection fraction: results from the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study","volume":"23","author":"Ibrahim","year":"2017","journal-title":"J\u00a0Card Fail"},{"issue":"2","key":"10.1016\/j.hfc.2019.06.006_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.003835","article-title":"Worsening renal function and mortality in heart failure: causality or confounding?","volume":"10","author":"Testani","year":"2017","journal-title":"Circ Heart Fail"},{"issue":"6","key":"10.1016\/j.hfc.2019.06.006_bib9","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1161\/HYPERTENSIONAHA.118.12051","article-title":"Creatinine bump following antihypertensive therapy","volume":"72","author":"Bakris","year":"2018","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.hfc.2019.06.006_bib10","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCHEARTFAILURE.111.963413","article-title":"Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function","volume":"5","author":"Metra","year":"2012","journal-title":"Circ Heart Fail"},{"issue":"22","key":"10.1016\/j.hfc.2019.06.006_bib11","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJM197111252852205","article-title":"Tubular reabsorption of sodium ion: influence of factors other than aldosterone and glomerular filtration rate. 1","volume":"285","author":"Schrier","year":"1971","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.hfc.2019.06.006_bib12","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial","volume":"285","author":"Agodoa","year":"2001","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.hfc.2019.06.006_bib13","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"issue":"9721","key":"10.1016\/j.hfc.2019.06.006_bib14","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(09)62100-0","article-title":"Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial","volume":"375","author":"Bakris","year":"2010","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.hfc.2019.06.006_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archinte.160.5.685","article-title":"Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?","volume":"160","author":"Bakris","year":"2000","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.hfc.2019.06.006_bib16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/ki.2011.79","article-title":"An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function","volume":"80","author":"Holtkamp","year":"2011","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.hfc.2019.06.006_bib17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1159\/000343453","article-title":"Tolerating increases in the serum creatinine following aggressive treatment of chronic kidney disease, hypertension and proteinuria: pre-renal success","volume":"36","author":"Hirsch","year":"2012","journal-title":"Am J Nephrol"},{"issue":"22","key":"10.1016\/j.hfc.2019.06.006_bib18","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hfc.2019.06.006_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.ajkd.2018.07.015","article-title":"Effects of intensive blood pressure lowering on kidney tubule injury in CKD: a longitudinal subgroup analysis in SPRINT","volume":"73","author":"Malhotra","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.hfc.2019.06.006_bib20","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7326\/M18-1037","article-title":"Kidney damage biomarkers and incident chronic kidney disease during blood pressure reduction: a case-control study","volume":"169","author":"Zhang","year":"2018","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.hfc.2019.06.006_bib21","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1161\/HYPERTENSIONAHA.118.11944","article-title":"Creatinine rise during blood pressure therapy and the risk of adverse clinical outcomes in patients with type 2 diabetes mellitus","volume":"72","author":"Collard","year":"2018","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.hfc.2019.06.006_bib22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1161\/CIRCHEARTFAILURE.111.963256","article-title":"Prognostic importance of early worsening renal function after initiation of angiotensin-converting enzyme inhibitor therapy in patients with cardiac dysfunction","volume":"4","author":"Testani","year":"2011","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.hfc.2019.06.006_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ejhf.13","article-title":"Worsening renal function during renin-angiotensin-aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction","volume":"16","author":"Clark","year":"2014","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.hfc.2019.06.006_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCHEARTFAILURE.107.746933","article-title":"Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF)","volume":"1","author":"Klein","year":"2008","journal-title":"Circ Heart Fail"},{"issue":"20","key":"10.1016\/j.hfc.2019.06.006_bib25","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1093\/eurheartj\/ehr238","article-title":"Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial","volume":"32","author":"Blair","year":"2011","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.hfc.2019.06.006_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.jchf.2015.05.009","article-title":"Competing risk of cardiac status and renal function during hospitalization for acute decompensated heart failure","volume":"3","author":"Salah","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"10","key":"10.1016\/j.hfc.2019.06.006_bib27","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cardfail.2016.06.423","article-title":"Relevance of changes in serum creatinine during a heart failure trial of decongestive strategies: insights from the DOSE trial","volume":"22","author":"Brisco","year":"2016","journal-title":"J\u00a0Card Fail"},{"issue":"2","key":"10.1016\/j.hfc.2019.06.006_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003588","article-title":"Renin-angiotensin system inhibition, worsening renal function, and outcome in heart failure patients with reduced and preserved ejection fraction: a meta-analysis of published study data","volume":"10","author":"Beldhuis","year":"2017","journal-title":"Circ Heart Fail"},{"issue":"11","key":"10.1016\/j.hfc.2019.06.006_bib29","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.hfc.2019.06.006_bib30","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jchf.2018.02.004","article-title":"Renal effects and associated outcomes during angiotensin-neprilysin inhibition in heart failure","volume":"6","author":"Damman","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"15","key":"10.1016\/j.hfc.2019.06.006_bib31","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCULATIONAHA.118.034818","article-title":"Effects of sacubitril\/valsartan versus irbesartan in patients with chronic kidney disease","volume":"138","author":"Haynes","year":"2018","journal-title":"Circulation"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713619300443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713619300443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:40:15Z","timestamp":1761554415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713619300443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1551713619300443"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2019.06.006","relation":{},"ISSN":["1551-7136"],"issn-type":[{"type":"print","value":"1551-7136"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart Failure and Changes in Kidney Function","name":"articletitle","label":"Article Title"},{"value":"Heart Failure Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hfc.2019.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}